Multifaceted roles of adiponectin in rheumatoid arthritis

被引:45
作者
Liu, Ding [1 ]
Luo, Shuaihantian [2 ]
Li, Zhihong [1 ]
机构
[1] Cent S Univ, Dept Orthopaed, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China
[2] Cent S Univ, Dept Dermatol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Adiponectin; Rheumatoid arthritis; Biomarker; Pro-inflammatory; Anti-; inflammatory; FIBROBLAST-LIKE SYNOVIOCYTES; NF-KAPPA-B; MOLECULAR-WEIGHT ADIPONECTIN; PROSTAGLANDIN E-2 PRODUCTION; COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; METABOLIC SYNDROME; MATRIX METALLOPROTEINASES; SYNOVIAL FIBROBLASTS; JOINT INFLAMMATION;
D O I
10.1016/j.intimp.2015.08.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adiponectin is a circulating hormone with pleiotropic functions in lipid and glucose metabolism secreted by adipocytes. It plays a beneficial role in cardiovascular functions and metabolic complications. Recently, growing researches have elucidated that increased adiponectin plasma levels correlate with severity of rheumatoid arthritis (RA) and it is speculative that adiponectin may link to RA. The association of adiponectin with potential inflammatory functions in RA has raised significant interests in exploring this adipokine as a target for RA-diagnostic and therapeutic applications. Despite significant advances in understanding adiponectin functions and signaling mechanisms, its roles in RA remain multifaceted and subject to controversy. This review highlights the evidences linking adiponectin to either anti-inflammatory or pro-inflammatory action in RA. The results of this review may provide important insight into adiponectin in the development of RA. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:1084 / 1090
页数:7
相关论文
共 99 条
[1]   Adipose tissue as an endocrine organ [J].
Ahima, Rexford S. .
OBESITY, 2006, 14 :242-249
[2]  
Alkady EAM, 2011, Z RHEUMATOL, V70, P602, DOI 10.1007/s00393-011-0834-2
[3]   Emerging cytokine targets in rheumatoid arthritis [J].
Asquith, Darren L. ;
McInnes, Iain B. .
CURRENT OPINION IN RHEUMATOLOGY, 2007, 19 (03) :246-251
[4]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[5]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[6]   Adiponectin, obesity and atherosclerosis [J].
Behre, C. J. .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2007, 67 (05) :449-458
[7]   Leptin and atherosclerosis [J].
Beltowski, Jerzy .
ATHEROSCLEROSIS, 2006, 189 (01) :47-60
[8]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[9]  
Bingham CO, 2002, J RHEUMATOL, V29, P3
[10]   Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes [J].
Borden, P ;
Solymar, D ;
Sucharczuk, A ;
Lindman, B ;
Cannon, P ;
Heller, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (38) :23577-23581